Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
作者信息
Lise M, Nitti D, Buyse M, Cartei G, Fornasiero A, Guimaraes dos Santos J, Duez N
机构信息
Istituto di Patologia Chirurgia 1a, Universita degli Studi di Padova, Italy.
出版信息
Recent Results Cancer Res. 1988;110:36-43. doi: 10.1007/978-3-642-83293-2_5.
PMID:3043595
Abstract
摘要
Zotero 插件